Rheumatic Heart Disease Study in Lusaka

• Register: ClinicalTrials.gov
• Last refreshed on: 14 November 2016
• Main ID: NCT02661763
• Date of registration: 19/01/2016
• Prospective Registration: No
• Primary sponsor: University of Zambia
• Public title: Rheumatic Heart Disease Study in Lusaka
• Scientific title: Prevalence of Rheumatic Heart Disease in Zambian Schoolchildren: an Echocardiographic Screening Study Involving Task-shifting to General Radiographers
• Date of first enrolment: September 2015
• Target sample size: 1024
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02661763
• Study type: Observational
• Study design: Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional
• Phase: N/A

Countries of recruitment

Zambia

Contacts

• Name: John Musuku, Doctor
• Affiliation: University of Zambia / University Teaching Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- Schoolgoing children in Lusaka in grades 7-12 at one of the participating primary or
secondary schools

- Written parental consent

- Written assent by children

- Present on the day of school screening

Exclusion Criteria:

- Children whose parents do not provide consent

- Children who do not provide assent

- Children with health problems (e.g., skin infection of the chest) that preclude
performance of transthoracic echocardiography



Age minimum: 10 Years
Age maximum: 21 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Rheumatic Heart Disease

Primary Outcome(s)

Prevalence of RHD in Lusaka schoolchildren [Time Frame: Cross-sectional; the screening period is anticipated to last 5 months]

Secondary ID(s)

UNZABREC 002-10-13

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

University of Cape Town

Novartis